Large B cell lymphoma-year by year
JAMC-Journal of Ayub Medical College-Abbotabad-Pakistan. 2007; 19 (4): 121-126
in English
| IMEMR
| ID: emr-83199
ABSTRACT
Non Hodgkin's Lymphoma [NHL] comprises a group of lymphoproliferative disorders the frequency of which continues to rise. Although many classification systems exist for identifying specific histological subtypes, NHL is generally divided into indolent [low-grade] and aggressive [intermediate- and high-grade] forms. Large B Cell Lymphoma [LBCL] is one of the commonest aggressive NHLs. The aim of this review is to provide a general overview of NHL, its clinically practicable cellular classification, epidemiology and in depth overview of the evolution of treatment of LBCL during the past 5 years. Current guidelines from National Cancer Institute [NCI], USA and National Institute on Clinical Excellence [NICE], UK are mentioned and recommendations according to our own set-up are suggested
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Lymphoma, Non-Hodgkin
/
Lymphoma, Large B-Cell, Diffuse
/
Antigens, CD20
/
Molecular Biology
/
Antibodies, Monoclonal
/
Antigens, Surface
Limits:
Humans
Language:
English
Journal:
J. Ayub Med. Coll.-Abbotabad-Pak.
Year:
2007
Similar
MEDLINE
...
LILACS
LIS